# Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors

> **NCT00957905** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 36 (actual)

## Conditions studied

- Recurrent Extragonadal Seminoma
- Recurrent Malignant Extragonadal Germ Cell Tumor
- Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor
- Recurrent Malignant Testicular Germ Cell Tumor
- Recurrent Ovarian Germ Cell Tumor
- Stage III Testicular Cancer
- Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor
- Stage IV Extragonadal Seminoma
- Stage IV Ovarian Germ Cell Tumor

## Interventions

- **DRUG:** Alvocidib Hydrochloride
- **DRUG:** Fluorouracil
- **DRUG:** Leucovorin Calcium
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT00957905
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00957905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00957905, "Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00957905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*